Network Analysis of Symptom Comorbidity in Schizophrenia: Relationship to Illness Course and Brain White Matter Microstructure

Abstract

Introduction Recent network-based analyses suggest that schizophrenia symptoms are intricately connected and interdependent, such that central symptoms can activate adjacent symptoms and increase global symptom burden. Here, we sought to identify key clinical and neurobiological factors that relate to symptom organization in established schizophrenia. Methods A symptom comorbidity network was mapped for a broad constellation of symptoms measured in 642 individuals with a schizophrenia-spectrum disorder. Centrality analyses were used to identify hub symptoms. The extent to which each patient’s symptoms formed clusters in the comorbidity network was quantified with cluster analysis and used to predict (1) clinical features, including illness duration and psychosis (positive symptom) severity and (2) brain white matter microstructure, indexed by the fractional anisotropy (FA), in a subset (n = 296) of individuals with diffusion-weighted imaging (DWI) data. Results Global functioning, substance use, and blunted affect were the most central symptoms within the symptom comorbidity network. Symptom profiles for some patients formed highly interconnected clusters, whereas other patients displayed unrelated and disconnected symptoms. Stronger clustering among an individual’s symptoms was significantly associated with shorter illness duration (t = 2.7; P = .0074), greater psychosis severity (ie, positive symptoms expression) (t = −5.5; P < 0.0001) and lower fractional anisotropy in fibers traversing the cortico-cerebellar-thalamic-cortical circuit (r = .59, P < 0.05). Conclusion Symptom network structure varies over the course of schizophrenia: symptom interactions weaken with increasing illness duration and strengthen during periods of high positive symptom expression. Reduced white matter coherence relates to stronger symptom clustering, and thus, may underlie symptom cascades and global symptomatic burden in individuals with schizophrenia.

Harmonized diffusion MRI data and white matter measures from the Adolescent Brain Cognitive Development Study

“…In all metrics, our algorithm was chosen as the best-performing method (Ning et al 2020;Tax et al 2019)). The effectiveness of our approach has also been demonstrated through several studies in schizophrenia and other disorders (Cetin Suheyla Cetin-Karayumak, Di Biase, et al 2020;Biase et al 2021;De Luca et al 2022;Seitz-Holland et al 2022;Suheyla Cetin-Karayumak et al, n.d.;Elad et al 2021;Ye et al 2021;Lv et al 2020;Hegde et al 2021;Kelly et al 2021;Levitt et al, n.d.;S. Cetin-Karayumak, Kubicki, and Rathi 2018).…”

Exploration of symptom clusters during hemodialysis and symptom network analysis of older maintenance hemodialysis patients: a cross-sectional study

“…In the process of data analysis, we excluded uncommon symptoms (prevalence < 10%) [ 30 – 32 ], including decreased interest in sex and difficulty becoming sexually aroused, from the analysis. These symptoms do not reflect the critical symptoms in the cluster and may interfere with the analysis and result interpretation.…”

Network analysis of neuropsychiatric, cognitive, and functional complications of stroke: implications for novel treatment targets

“…For each network, missing data were handled iteratively, whereby subject rows or item columns with >30% missing data were removed in a first step. 26 In a second step, remaining missing data were imputed using probabilistic principal component analysis. All scores were transformed into z scores by applying a quantile normalization.…”